| MPJE JERSEY |
Licenses and Privileges |
Unfinished |
2007-09-16 |
vitasoy |
15 |
0 |
edit |
|
| MPJE JERSEY |
CS Drugs and its Schedules |
Unfinished |
2007-09-17 |
vitasoy |
56 |
0 |
edit |
|
| MPJE JERSEY |
FEDERAL LAW |
Unfinished |
2007-09-17 |
vitasoy |
278 |
0 |
edit |
|
| MPJE JERSEY |
Poison Packaging Prevention Act |
Unfinished |
2007-09-16 |
vitasoy |
31 |
0 |
edit |
|
| MPJE JERSEY |
NEW JERSEY BOARD OF PHARMACY REGULATIONS |
Unfinished |
2021-09-28 |
vitasoy |
246 |
2 |
edit |
|
| MPJE JERSEY |
SHIVVY |
Unfinished |
2007-09-17 |
vitasoy |
50 |
0 |
edit |
|
| MPJE NEVADA |
MPJE NEVADA |
Unfinished |
2013-02-19 |
vitasoy |
38 |
1 |
edit |
|
| NAPLEX REVIEW |
Antagonists |
Unfinished |
2007-10-11 |
vitasoy |
14 |
0 |
edit |
|
| NAPLEX REVIEW |
Glaucoma |
Unfinished |
2007-10-15 |
vitasoy |
33 |
0 |
edit |
|
| NAPLEX REVIEW |
Antacids |
Unfinished |
2007-10-15 |
vitasoy |
19 |
0 |
edit |
|
| NAPLEX REVIEW |
Asthma |
Unfinished |
2007-10-03 |
vitasoy |
5 |
0 |
edit |
|
| NAPLEX REVIEW |
Calculations |
Unfinished |
2007-10-16 |
vitasoy |
30 |
0 |
edit |
|
| NAPLEX REVIEW |
Pharmacokinetics I |
Unfinished |
2007-10-15 |
vitasoy |
21 |
2 |
edit |
|
| NAPLEX REVIEW |
Equations |
Unfinished |
2007-10-08 |
vitasoy |
13 |
0 |
edit |
|
| Naplex Review |
Top 200 |
Unfinished |
2007-10-16 |
vitasoy |
231 |
0 |
edit |
|
| Naplex Review |
Biologicals |
Unfinished |
2007-10-11 |
vitasoy |
55 |
0 |
edit |
|
| NAPLEX REVIEW |
Pharmacology |
Unfinished |
2007-10-11 |
vitasoy |
7 |
0 |
edit |
|
| NAPLEX REVIEW |
Infectious Disease |
Unfinished |
2007-10-12 |
vitasoy |
98 |
0 |
edit |
|
| NAPLEX REVIEW |
3A4 Inhibitors |
Unfinished |
2007-10-16 |
vitasoy |
29 |
0 |
edit |
|
| NAPLEX REVIEW |
3A4 Inducers |
Unfinished |
2007-10-11 |
vitasoy |
15 |
0 |
edit |
|
| NAPLEX REVIEW |
Tuberculosis and Urinary |
Unfinished |
2007-10-16 |
vitasoy |
20 |
0 |
edit |
|
| NAPLEX REVIEW |
Malaria |
Unfinished |
2007-10-12 |
vitasoy |
7 |
0 |
edit |
|
| NAPLEX REVIEW |
Fungal |
Unfinished |
2007-10-14 |
vitasoy |
15 |
0 |
edit |
|
| NAPLEX REVIEW |
HIV |
Unfinished |
2007-10-16 |
vitasoy |
54 |
0 |
edit |
|
| NAPLEX REVIEW |
Influenza |
Unfinished |
2007-10-14 |
vitasoy |
19 |
0 |
edit |
|
| NAPLEX REVIEW |
CHF |
Unfinished |
2007-10-14 |
vitasoy |
46 |
0 |
edit |
|
| NAPLEX REVIEW |
Hypertension |
Unfinished |
2007-10-14 |
vitasoy |
47 |
0 |
edit |
|
| NAPLEX REVIEW |
Vitamins |
Unfinished |
2007-10-14 |
vitasoy |
22 |
0 |
edit |
|
| NAPLEX REVIEW |
Seizures |
Unfinished |
2007-10-15 |
vitasoy |
52 |
0 |
edit |
|
| NAPLEX REVIEW |
Parkinsons Disease |
Unfinished |
2007-10-15 |
vitasoy |
24 |
0 |
edit |
|
| NAPLEX REVIEW |
Diabetes |
Unfinished |
2013-06-06 |
vitasoy |
90 |
1 |
edit |
|
| NAPLEX REVIEW |
Pharmacokinetics I |
Unfinished |
2007-10-15 |
vitasoy |
30 |
0 |
edit |
|
| NAPLEX REVIEW |
References |
Unfinished |
2007-10-16 |
vitasoy |
17 |
0 |
edit |
|
| NAPLEX REVIEW |
Radiopharmaceuticals |
Unfinished |
2007-10-15 |
vitasoy |
23 |
0 |
edit |
|
| NAPLEX REVIEW |
Vitamins |
Unfinished |
2007-10-15 |
vitasoy |
18 |
0 |
edit |
|
| NAPLEX REVIEW |
Sterilization Terminology and Methods |
Unfinished |
2007-10-16 |
vitasoy |
25 |
0 |
edit |
|
| NAPLEX REVIEW |
Cystic Fibrosis |
Unfinished |
2016-06-14 |
vitasoy |
10 |
1 |
edit |
|
| NAPLEX REVIEW |
Nutrition Support |
Unfinished |
2014-03-10 |
vitasoy |
50 |
2 |
edit |
|
| NAPLEX REVIEW |
Cancer |
Unfinished |
2007-10-16 |
vitasoy |
6 |
0 |
edit |
|
| MPJE NEVADA |
MPJE NEVADA (2) |
Unfinished |
2022-01-27 |
vitasoy |
35 |
2 |
edit |
|
| MPJE NEVADA |
MPJE NEVADA (3) |
Unfinished |
2022-01-27 |
vitasoy |
98 |
2 |
edit |
|
| MPJE NEVADA |
MPJE NEVADA (4) Software |
Unfinished |
2022-01-27 |
vitasoy |
66 |
2 |
edit |
|
| MPJE NEVADA |
Scheduling Limitations |
Unfinished |
2022-01-27 |
vitasoy |
12 |
1 |
edit |
|
| MPJE NEVADA |
MPJE NEVADA (5) |
Unfinished |
2022-01-27 |
vitasoy |
88 |
4 |
edit |
|